JPMorgan analyst Chris Schott raised the firm’s price target on Eli Lilly to $400 from $380 and keeps an Overweight rating on the shares. The analyst sees "encouraging" core product and pipeline traction.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on LLY: